Court Considers How Much Deference FDA Should Get In Legal Challenges
April 2, 2019
Mari Serebrov
BioWorld
Axinn partner Chad Landmon was quoted in the BioWorld article, "Court Considers How Much Deference FDA Should Get In Legal Challenges."
Click here to access the article. A subscription is required.